Remission & chronicity

Spontaneous remission

Mild CTS: spontaneous resolution in 30-40% within 12 months without treatment; moderate-severe: <5% spontaneous resolution; pregnancy-related CTS resolves in 80% post-delivery

Best-intervention remission

Surgical decompression (carpal tunnel release, CTR): 90% symptom resolution at 12 months; 85% satisfaction at 5 years; superior to splinting at 6 months (SEVIORAL trial); corticosteroid injection: 75% improvement at 4 weeks, 50% at 6 months, 20% at 12 months

Gap size

Small — surgery is highly effective; the question is appropriate timing and selecting patients for non-surgical management

Primary barrier

practice/framing

Surgery is underused in some health systems where patients are kept on conservative management (splinting, cortisone) for years with progressive nerve damage; conversely, overused in mild cases where non-surgical management could suffice; ergonomic intervention is chronically under-addressed

Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.

Pipeline results not yet available. Run: python -m biomarker_pipeline.run_for_diseases --skip-llm

Clinical Trials

Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-06.

No recent clinical trials found on ClinicalTrials.gov for this condition.

Agents Found By Disease-Level Search

Searched directly from “Carpal Tunnel Syndrome” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 0-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

Not yet run. python -m biomarker_pipeline.run_disease_agent_discovery --disease "..."

Carpal Tunnel Syndrome

Remission & chronicity

Part of the Open Source Medicine Foundation Network